ARE

Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates

Retrieved on: 
Thursday, August 3, 2023

Avalo is considering out-licensing or sale of its non-core and potentially its core assets to increase focus and reduce future expenses.

Key Points: 
  • Avalo is considering out-licensing or sale of its non-core and potentially its core assets to increase focus and reduce future expenses.
  • In July of 2023, Avalo entered into a non-binding letter of intent for the potential sale of AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose).
  • Second Quarter 2023 Financial Update:
    Avalo had $6.3 million in cash and cash equivalents as of June 30, 2023, representing a $6.9 million decrease compared to December 31, 2022.
  • The net loss and net loss per share for the three months ended June 30, 2023 was largely driven by operating expenses.

Pomerantz LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of 22nd Century Group, Inc. Common Stock

Retrieved on: 
Monday, July 31, 2023

SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION, CERTIFICATION OF SETTLEMENT CLASS, AND PROPOSED SETTLEMENT OF CLASS ACTION; (II) SETTLEMENT HEARING; AND (III) MOTION FOR AN AWARD OF

Key Points: 
  • SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION, CERTIFICATION OF SETTLEMENT CLASS, AND PROPOSED SETTLEMENT OF CLASS ACTION; (II) SETTLEMENT HEARING; AND (III) MOTION FOR AN AWARD OF
    TO:  All persons and entities who, during the period from February 18, 2016 through July 31, 2019, inclusive (the "Settlement Class Period"), purchased or otherwise acquired 22nd Century Group, Inc. ("22nd Century") common stock and were allegedly damaged thereby (the "Settlement Class").
  • PLEASE READ THIS NOTICE CAREFULLY, YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
  • YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $3,000,000.00 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action.
  • If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.

Should companies have separate sick days for stress? - A study shows that 44% of people take sick days due to stress

Retrieved on: 
Wednesday, July 26, 2023

MONTREAL, July 26, 2023 /PRNewswire-PRWeb/ -- In the time of our grandparents, taking a day off from work due to illness was rare, and missing work as a result of stress was even rarer. To do so would mean no pay for the day, risking the loss of their job, and perhaps even ridicule. We now have the luxury of sick days, but as a study from the researchers at PsychTests reveals, many people are using them as "de-stress days," especially individuals who struggle to cope with the pressures of their job and everyday life. This begs the question: should it become standard practice to provide employees with mental health days in addition to sick days?

Key Points: 
  • To do so would mean no pay for the day, risking the loss of their job, and perhaps even ridicule.
  • This begs the question: should it become standard practice to provide employees with mental health days in addition to sick days?
  • The bottom line is that sick days are not being used solely for physical illness anymore.
  • This means that stress levels are becoming extreme, to the point where people are struggling to function in everyday life."

Nano Dimension Sets the Record Straight for Stratasys Shareholders

Retrieved on: 
Tuesday, July 25, 2023

The Stratasys Board has demonstrated a blatant disregard for shareholders’ interests and resistance to change.

Key Points: 
  • The Stratasys Board has demonstrated a blatant disregard for shareholders’ interests and resistance to change.
  • These actions demonstrate a lack of strategic foresight and a failure to prioritize long-term value creation for the company and its shareholders.
  • Copies of the documents filed with the SEC by Stratasys may be obtained at no charge on the investor relations page of Stratasys’ website at www.stratasys.com.
  • Copies of the documents filed with the SEC by Nano Dimension may be obtained at no charge on the investor relations page of Nano Dimension’s website at www.nano-di.com .

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Maxar Technologies Securities Litigation

Retrieved on: 
Monday, July 24, 2023

IT IS NOT A LAWYER SOLICITATION.

Key Points: 
  • IT IS NOT A LAWYER SOLICITATION.
  • To determine whether the date and time of the Settlement Hearing have changed, it is important that you monitor the Court’s docket and the Settlement website before making any plans to attend the Settlement Hearing.
  • Any updates regarding the Settlement Hearing, including any changes to the date or time of the hearing, will also be posted to the Settlement website, www.MaxarSecuritiesClassLitigation.com .
  • If you are a Member of the Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.

Bernstein Litowitz Berger & Grossmann LLP Announces Pendency of Class Action and Proposed Settlement For Purchasers of BioMarin Pharmaceutical Inc. Common Stock from March 3, 2020 through August 18, 2020, Inclusive

Retrieved on: 
Wednesday, July 12, 2023

YOU ARE ALSO NOTIFIED that Lead Plaintiff Arbejdsmarkedets Tillægspension and Defendants BioMarin, Jean-Jacques Bienaimé, and Dr. Henry Fuchs have reached a proposed settlement of the Action on behalf of the Settlement Class for $39,000,000 in cash (the "Settlement").

Key Points: 
  • YOU ARE ALSO NOTIFIED that Lead Plaintiff Arbejdsmarkedets Tillægspension and Defendants BioMarin, Jean-Jacques Bienaimé, and Dr. Henry Fuchs have reached a proposed settlement of the Action on behalf of the Settlement Class for $39,000,000 in cash (the "Settlement").
  • If approved by the Court, the Settlement will resolve all claims in the Action.
  • If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement proceeds.
  • All questions about this notice, the Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

Altaaqa Renewables, a Zahid Group company, to build Wadi ad-Dawasir 119MW Solar Power Plant together with TotalEnergies and Toyota Tsusho Corporation

Retrieved on: 
Tuesday, July 11, 2023

The Consortium will finance, build, own and operate the PV plant that will generate renewable energy for the Kingdom’s Central Region.

Key Points: 
  • The Consortium will finance, build, own and operate the PV plant that will generate renewable energy for the Kingdom’s Central Region.
  • The achievement follows the Consortium being awarded the project by the Saudi Power Procurement Company.
  • Currently there are renewable energy projects in advanced stages, which, once complete, will generate more than 4,500 MWp, powering over 650,000 homes across the Kingdom.
  • ARE develops, finances, builds, and operates utility scale renewable energy, energy storage and hybrid projects that use the most advance and cost-efficient onshore wind and solar technologies.

Pomerantz LLP and Glancy Prongay & Murray LLP Announce Pendency of Class Action and Proposed Settlement To All Persons and Entities who Purchased or Otherwise Acquired Community Health Common Stock during the Period Between February 21, 2017, and February

Retrieved on: 
Monday, July 10, 2023

YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $9,500,000 in cash (the "Settlement"), which, if approved, will resolve all claims in the Action.

Key Points: 
  • YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $9,500,000 in cash (the "Settlement"), which, if approved, will resolve all claims in the Action.
  • If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.
  • Please do not contact the Court, the Clerk's office, Community Health Systems, Inc., or its counsel regarding this notice.
  • Inquiries, other than requests for the Notice and Claim Form, should be made to Lead Counsel:

Pomerantz LLP and Glancy Prongay & Murray LLP Announce Pendency of Class Action and Proposed Settlement To All Persons and Entities who Purchased or Otherwise Acquired Community Health Common Stock during the Period Between February 21, 2017, and February

Retrieved on: 
Monday, July 10, 2023

YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $9,500,000 in cash (the "Settlement"), which, if approved, will resolve all claims in the Action.

Key Points: 
  • YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $9,500,000 in cash (the "Settlement"), which, if approved, will resolve all claims in the Action.
  • If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund.
  • Please do not contact the Court, the Clerk's office, Community Health Systems, Inc., or its counsel regarding this notice.
  • Inquiries, other than requests for the Notice and Claim Form, should be made to Lead Counsel:

Fresenius Medical Care appoints Martin Fischer as Chief Financial Officer

Retrieved on: 
Monday, July 10, 2023

WALTHAM, Mass., July 10, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023. He will succeed Helen Giza who was appointed as Chief Executive Officer and Chair of the Management Board in December 2022 and continues to serve as acting Chief Financial Officer, until her successor will join. Martin Fischer will be based in Bad Homburg, Germany and will assume responsibility for the Global Finance Organization of Fresenius Medical Care. Upon effectiveness of the Company's proposed change of form from KGaA to German stock corporation, Martin Fischer will become a member of the Management Board of Fresenius Medical Care AG.

Key Points: 
  • WALTHAM, Mass., July 10, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023.
  • Martin Fischer will be based in Bad Homburg, Germany and will assume responsibility for the Global Finance Organization of Fresenius Medical Care.
  • Upon effectiveness of the Company's proposed change of form from KGaA to German stock corporation, Martin Fischer will become a member of the Management Board of Fresenius Medical Care AG.
  • Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care Management AG, says: "With Martin Fischer's appointment, we are strengthening a vital function in the Management Board of Fresenius Medical Care.